You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
PWNHealth will be rebranded as Everly Health Solutions and will operate as an independent subsidiary of newly-formed parent company Everly Health.
The company was founded in 2017 to commercialize a small, battery-powered, disposable RT-PCR system called the Nuclein Hand-Held PCR Test.
NeoGenomics will offer Trapelo's clinical decision support system to providers, payors, and labs to aid precision oncology across all healthcare settings.
The firm used the proceeds to repay outstanding borrowings of $25.9 million under its existing loan with Innovatus Life Sciences Lending Fund.
The review, which Goldman Sach will advise on, is possibly a response to activist investor Jana Partners, which bought a large stake in the company last year.
With support from Color and through a network of testing laboratories, Thermo Fisher will offer integrated COVID-19 testing to school districts nationwide.
The partners believe the platform, which captures high resolution images of CTCs and clusters, has potential applications in early cancer detection and disease monitoring.
While the reforms ease some providers' shift to value-based care, their exclusion of labs could hamper the industry's move into population health and other areas.
The test measures IgG antibodies directed to the spike protein of the virus and has demonstrated 99.9 percent specificity and 98.9 percent sensitivity.
The financing will go toward the expansion of the company's laboratory operations and acceleration of the sales and marketing efforts of its Syn-One Test.